Abstract: The present invention relates to a virtual sports system and a virtual sports device that may be used in the virtual sports system. The virtual sports system comprises a terminal device, a service device accessible by the terminal device and a virtual sports device communicatively connected to the service device, wherein when a user requests to provide content through the terminal device, information on the requested content is delivered to the virtual sports device through the service device, and the virtual sports device provides the content to another user playing in the virtual sports device.

Abstract: Various aspects of the present disclosure generally relate to wireless communication. In some aspects, a first wireless communication device may receive, from a second wireless communication device, a discovery message that includes a service code. The first wireless communication device may verify the service code. The first wireless communication device may transmit, to the second wireless communication device, a connection message that includes a protected service code that is derived from the service code. Numerous other aspects are described.

Abstract: The present invention relates to an in-vivo bulking agent which can be used as a medicinal agent for prevention or treatment of at least one disease selected from the group consisting of urinary incontinence, fecal incontinence, and gastroesophageal reflux or as a filler for use in a plastic surgery procedure, and to a preparation method therefor. The in-vivo bulking agent can exhibit a bulking effect when injected into the body and particularly, is highly biocompatible because a first composition in which silicone particles are coated with a zwitterionic polymer having a surfactant property is introduced into a second composition, whereby the bulking agent can inhibit inflammatory reactions in vivo.

Abstract: Embodiments of the present invention provide a semiconductor device capable of reducing parasitic capacitance between neighboring conductive lines and a method for fabricating the same. According to an embodiment of the present invention, a semiconductor device comprises: a conductive line formed over a substrate; and a multi-layered spacer covering both sidewalls of the conductive line, wherein the multi-layered spacer is stacked in the order of a diffusion barrier material, boron nitride layer, and an antioxidant material.

Abstract: Systems and techniques are disclosed to protect a user equipment's international mobile subscriber identity by providing a privacy mobile subscriber identity instead. In an attach attempt to a serving network, the UE provides the PMSI instead of IMSI, protecting the IMSI from exposure. The PMSI is determined between a home network server and the UE so that intermediate node elements in the serving network do not have knowledge of the relationship between the PMSI and the IMSI. Upon receipt of the PMSI in the attach request, the server generates a next PMSI to be used in a subsequent attach request and sends the next PMSI to the UE for confirmation. The UE confirms the next PMSI to synchronize between the UE and server and sends an acknowledgment token to the server. The UE and the server then each update local copies of the current and next PMSI values.

Abstract: A method, operational at a device, includes receiving at least one packet belonging to a first set of packets of a packet flow marked with an identification value, determining that the at least one packet is marked with the identification value, determining to change a quality of service (QoS) treatment of packets belonging to the first set of packets marked with the identification value that are yet to be received, and sending a request to change the QoS treatment of packets belonging to the first set of packets marked with the identification value that are yet to be received to trigger a different QoS treatment of packets within the packet flow, responsive to determining to change the QoS treatment. Other aspects, embodiments, and features are also claimed and described.

Abstract: The lipstick container includes: a case 3 that has a cylindrical shape and includes a protrusion 21 formed to protrude from the inside thereof; a protective tube 5 rotatably mounted on an upper portion of the case 3; inner containers 7a and 7b that are rotatably disposed on an inner surface of the case 3 and in which the protrusion 21 of the case 3 is coupled to grooves thereof formed in an vertical direction to rotate together when the case 3 rotates and that includes first and second containers 7a and 7b; a screw shaft 9 disposed at an inner side of the case 3 so as to be movable up and down; raising/lowering parts 11a and 11b which are screwed between the inner containers 7a and 7b and the screw shaft 9 to selectively raise or lower the screw shaft 9.

Abstract: A heating wire apparatus for a vehicle safety glass includes: a plurality of bus bars located at a periphery of the vehicle safety glass; a plurality of heating wires having a serial pattern between the plurality of bus bars; and a battery that applies a voltage to the plurality of heating wires.

Abstract: Various aspects of the present disclosure generally relate to wireless communication. In some aspects, a device may transmit, via a broadcast, a first frame that indicates one or more of a device credential or a payload. The device may receive, from the access point, a second frame that indicates one or more of the payload or an access point credential. The device may associate with the access point based at least in part on the access point credential. The device may perform a communication, to a cloud computing system via the access point, after the device has been associated with the access point. Numerous other aspects are described.

Abstract: Proposed is a pharmaceutical composition for oral administration, the composition including an ionic bond complex composed of teriparatide, deoxycholic acid, N?-deoxycholyl-L-lysyl-methylester (DCK), and di-alpha-tocopherol polyethylene glycol 1000 succinate, and a method for preparing the same is also proposed. The oral pharmaceutical composition is useful for the treatment of osteoporosis because the pharmaceutical composition can increase intestinal membrane permeability and oral administration bioavailability of teriparatide and improve patient compliance.

Abstract: A display device including a substrate including a display region and a non-display region disposed at one side of the display region, the display region includes first and second areas adjacent to each other; a display unit disposed on a front surface of the substrate, the display unit including a plurality of pixels for displaying an image; a cushion layer disposed on a rear surface of the substrate, the cushion layer including a first opening portion corresponding to the first area; a fingerprint sensor provided in the first opening portion of the cushion layer, the fingerprint sensor sensing a fingerprint of a user; and a first light-blocking layer disposed on a rear surface of the substrate, the first light-blocking layer covering at least part of the cushion layer and a lower surface of the fingerprint sensor.

Abstract: The present invention relates to guanidine compounds for inhibiting mitochondrial oxidative phosphorylation (OXPHOS) and use thereof. More specifically, the present invention relates to a pharmaceutical composition for preventing or treating a OXPHOS-related disease, particularly cancer, by inhibiting mitochondrial oxidative phosphorylation and reprogramming cellular metabolism.

Abstract: Various aspects of the present disclosure generally relate to wireless communication. In some aspects, a user equipment (UE) may transmit to a base station (BS), information indicating a medium access control (MAC) security capability of the UE. The UE may receive from the BS, a communication that includes an indication of a MAC security configuration for communications between the UE and the BS. The indication of the MAC security configuration may be based at least in part on the MAC security capability of the UE. Numerous other aspects are provided.

Abstract: A user equipment (UE) may experience poor communication with a network access device, and the network access device may configure the UE to connect to, and route communications through, one or more relay nodes (e.g., which may be another UE, a network operator-deployed relay, etc.). Techniques are described whereby these relay nodes may autonomously form a wireless backhaul network. Sequential implementations are considered such that the size of the wireless backhaul network may scale efficiently. In some examples, the wireless backhaul network may form by reusing existing connectivity establishment procedures. Importantly, the proposed techniques enable a relay to possess (e.g., be configured with) functionality that may traditionally be associated with a UE, base station, and gateway. Such multi-faceted functionality may enable the described sequential formation of wireless backhaul networks with tree topology.

Abstract: Disclosed is an information processing method in an electronic apparatus, which includes acquiring, from a user, first information related to supply including information on a target fulfillment center and information on an item, confirming a delivery type of the supply, acquiring scheduled arrival time information of the item according to the supply according to a method corresponding to the confirmed delivery type of the supply, and providing second information including the information on the item and the scheduled arrival time information to the target fulfillment center, in which the acquiring of the scheduled arrival time information includes acquiring an item arrival time calculation model that is pre-trained, and determining the scheduled arrival time information based on the item arrival time calculation model.

Abstract: A user equipment (UE) may receive system information from a base station and may calculate a hash value using the system information as input to a hashing function. Similarly, prior to transmitting the system information, a valid base station may calculate a hash value using the system information as input to a hashing function. The base station may transmit the calculated hash value (e.g., which represent or be included in a set of hash values) to the UE in an access stratum (AS) security mode command (SMC) message. The UE may determine whether the received system information was modified based on the hash value (e.g., by comparing the UE calculated hash value and the set of hash values received from the base station in the AS SMC). If the UE indicates a mismatch of hash information, the base station may re-transmit the system information (e.g., in an integrity protected message).

Abstract: Techniques are described for wireless communication. A method for wireless communication at a user equipment (UE) includes performing an extensible authentication protocol (EAP) procedure with an authentication server via an authenticator. The EAP procedure is based at least in part on a set of authentication credentials exchanged between the UE and the authentication server. The method also includes deriving, as part of performing the EAP procedure, a master session key (MSK) and an extended master session key (EMSK) that are based at least in part on the authentication credentials and a first set of parameters; determining a network type associated with the authenticator; and performing, based at least in part on the determined network type, at least one authentication procedure with the authenticator. The at least one authentication procedure is based on an association of the MSK or the EMSK with the determined network type.

Abstract: Provided are an oral delivery composition including oxaliplatin, a water-soluble anticancer agent, and a preparation method thereof, including forming an ionic complex with a bile acid derivative, which is an oral absorption promoter, and oxaliplatin, and incorporating it into the inner aqueous phase of a water-in-oil-in-water (w/o/w) multiple nanoemulsions, thereby obtaining the oral delivery composition with improved oral bioavailability of oxaliplatin, a water-soluble anticancer agent, avoiding the inconvenience and problems of injection, improving patient compliance, and reducing medical costs.

Abstract: Techniques are described for wireless communication. A method of wireless communication at a transmitting wireless device includes generating a first Message Authentication Code for a data packet based at least in part on a first security key used to communicate with a receiving wireless device; generating a second message authentication code for the data packet based at least in part on a second security key used to communicate with a relay user equipment (UE), in which the relay UE is included in a data routing path between the transmitting wireless device and the receiving wireless device; and transmitting the data packet to the relay UE with at least the first message authentication code and the second message authentication code.

Abstract: Certain aspects of the present disclosure provide techniques for detecting false base stations and transmissions therefrom based on silent periods during which legitimate base stations are to refrain from transmitting at least certain downlink transmissions on at least some downlink resources.